Cell Growth & Differentiation, Vol 2, Issue 2 95-105, Copyright © 1991 by American Association of Cancer Research

ARTICLES

Mechanism of activation of the vav protooncogene

J Coppola, S Bryant, T Koda, D Conway and M Barbacid
Department of Molecular Biology, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543.

vav is a human locus that appears to be specifically expressed in cells of hematopoietic origin regardless of their differentiation lineage. This gene was first identified as a result of its malignant activation during the course of gene transfer assays (Katzav, S., Martin-Zanca, D., and Barbacid, M. EMBO J., 8: 2283-2290, 1989). In this study, we report the isolation of complementary DNA clones containing the entire coding sequence of the mouse vav protooncogene. Antisera raised against a peptide corresponding to a predicted hydrophilic domain have allowed us to identify the product of the vav gene as a 95,000 Da protein. Analysis of the deduced amino acid sequence of p95vav revealed an amino-terminal leucine-rich region not present in the activated vav oncogene. This region consists of an amphipathic helix-loop-helix followed by a leucine zipper, a structure reminiscent of the carboxy-terminal region of myc proteins and the steroid binding domain of nuclear receptors. In vitro mutagenicity studies have indicated that removal of the amphipathic helix-loop-helix is sufficient to activate the transforming potential of human and mouse vav protooncogenes. vav proteins also possess a cysteine-rich domain whose sequence predicts the formation of two putative metal binding-like domains, Cys-X2-Cys-X13-Cys-X2-Cys and His-X2-Cys-X6-Cys-X2-His. Replacement of some of these cysteine and histidine residues completely abolished the transforming activity of vav genes. Further examination of the alignment of cysteine residues in this region revealed an alternative structure, Cys-X2-Cys-X13-Cys-X2-Cys-X7-Cys-X6-Cys, which is reminiscent of the phorbol ester binding domain of protein kinase C. A similar domain has been recently identified in a second enzyme, diacylglycerol kinase. These structural similarities, along with its expression pattern, suggest that the vav protooncogene codes for a new type of signal-transducing molecule that may play an important role in controlling hematopoiesis.

This article has been cited by other articles:

				V. Schapira, G. Lazer, and S. Katzav Osteopontin Is an Oncogenic Vav1- but not Wild-type Vav1-Responsive Gene: Implications for Fibroblast Transformation. Cancer Res., June 15, 2006; 66(12): 6183 - 6191. [Abstract] [Full Text] [PDF]

				L. S. Lyons and K. L. Burnstein Vav3, a Rho GTPase Guanine Nucleotide Exchange Factor, Increases during Progression to Androgen Independence in Prostate Cancer Cells and Potentiates Androgen Receptor Transcriptional Activity Mol. Endocrinol., May 1, 2006; 20(5): 1061 - 1072. [Abstract] [Full Text] [PDF]

				T. Kawakatsu, H. Ogita, T. Fukuhara, T. Fukuyama, Y. Minami, K. Shimizu, and Y. Takai Vav2 as a Rac-GDP/GTP Exchange Factor Responsible for the Nectin-induced, c-Src- and Cdc42-mediated Activation of Rac J. Biol. Chem., February 11, 2005; 280(6): 4940 - 4947. [Abstract] [Full Text] [PDF]

				S. Carrasco and I. Merida Diacylglycerol-dependent Binding Recruits PKC{theta} and RasGRP1 C1 Domains to Specific Subcellular Localizations in Living T Lymphocytes Mol. Biol. Cell, June 1, 2004; 15(6): 2932 - 2942. [Abstract] [Full Text] [PDF]

				S. A. Godambe, K. M. Knapp, E. A. Meals, and B. K. English Role of vav1 in the Lipopolysaccharide-Mediated Upregulation of Inducible Nitric Oxide Synthase Production and Nuclear Factor for Interleukin-6 Expression Activity in Murine Macrophages Clin. Vaccine Immunol., May 1, 2004; 11(3): 525 - 531. [Abstract] [Full Text] [PDF]

				M. Groysman, I. Hornstein, A. Alcover, and S. Katzav Vav1 and Ly-GDI Two Regulators of Rho GTPases, Function Cooperatively as Signal Transducers in T Cell Antigen Receptor-induced Pathways J. Biol. Chem., December 13, 2002; 277(51): 50121 - 50130. [Abstract] [Full Text] [PDF]

				T. R. Palmby, K. Abe, and C. J. Der Critical Role of the Pleckstrin Homology and Cysteine-rich Domains in Vav Signaling and Transforming Activity J. Biol. Chem., October 11, 2002; 277(42): 39350 - 39359. [Abstract] [Full Text] [PDF]

				M. A. Booden, S. L. Campbell, and C. J. Der Critical but Distinct Roles for the Pleckstrin Homology and Cysteine-Rich Domains as Positive Modulators of Vav2 Signaling and Transformation Mol. Cell. Biol., April 15, 2002; 22(8): 2487 - 2497. [Abstract] [Full Text] [PDF]

				C V Clevenger and J B Kline Prolactin receptor signal transduction Lupus, October 1, 2001; 10(10): 706 - 718. [Abstract] [PDF]

				L. Zeng, P. Sachdev, L. Yan, J. L. Chan, T. Trenkle, M. McClelland, J. Welsh, and L.-H. Wang Vav3 Mediates Receptor Protein Tyrosine Kinase Signaling, Regulates GTPase Activity, Modulates Cell Morphology, and Induces Cell Transformation Mol. Cell. Biol., December 15, 2000; 20(24): 9212 - 9224. [Abstract] [Full Text]

				S. P. Hehner, T. G. Hofmann, O. Dienz, W. Droge, and M. L. Schmitz Tyrosine-phosphorylated Vav1 as a Point of Integration for T-cell Receptor- and CD28-mediated Activation of JNK, p38, and Interleukin-2 Transcription J. Biol. Chem., June 9, 2000; 275(24): 18160 - 18171. [Abstract] [Full Text] [PDF]

				X. R. Bustelo Regulatory and Signaling Properties of the Vav Family Mol. Cell. Biol., March 1, 2000; 20(5): 1461 - 1477. [Full Text]

				M. López-Lago, H. Lee, C. Cruz, N. Movilla, and X. R. Bustelo Tyrosine Phosphorylation Mediates Both Activation and Downmodulation of the Biological Activity of Vav Mol. Cell. Biol., March 1, 2000; 20(5): 1678 - 1691. [Abstract] [Full Text]

				S. Ogilvy, D. Metcalf, C. G. Print, M. L. Bath, A. W. Harris, and J. M. Adams Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival PNAS, December 21, 1999; 96(26): 14943 - 14948. [Abstract] [Full Text] [PDF]

				N. Movilla and X. R. Bustelo Biological and Regulatory Properties of Vav-3, a New Member of the Vav Family of Oncoproteins Mol. Cell. Biol., November 1, 1999; 19(11): 7870 - 7885. [Abstract] [Full Text] [PDF]

				K. Abe, I. P. Whitehead, J. P. O'Bryan, and C. J. Der Involvement of NH2-terminal Sequences in the Negative Regulation of Vav Signaling and Transforming Activity J. Biol. Chem., October 22, 1999; 274(43): 30410 - 30418. [Abstract] [Full Text] [PDF]

				A. Germani, F. Romero, M. Houlard, J. Camonis, S. Gisselbrecht, S. Fischer, and N. Varin-Blank hSiah2 Is a New Vav Binding Protein Which Inhibits Vav-Mediated Signaling Pathways Mol. Cell. Biol., May 1, 1999; 19(5): 3798 - 3807. [Abstract] [Full Text] [PDF]

				S. Montaner, R. Perona, L. Saniger, and J. C. Lacal Activation of Serum Response Factor by RhoA Is Mediated by the Nuclear Factor-kappa B and C/EBP Transcription Factors J. Biol. Chem., March 26, 1999; 274(13): 8506 - 8515. [Abstract] [Full Text] [PDF]

				J. K. Westwick, R. J. Lee, Q. T. Lambert, M. Symons, R. G. Pestell, C. J. Der, and I. P. Whitehead Transforming Potential of Dbl Family Proteins Correlates with Transcription from the Cyclin D1 Promoter but Not with Activation of Jun NH2-terminal Kinase, p38/Mpk2, Serum Response Factor, or c-Jun J. Biol. Chem., July 3, 1998; 273(27): 16739 - 16747. [Abstract] [Full Text] [PDF]

				S. Ogilvy, A. G. Elefanty, J. Visvader, M. L. Bath, A. W. Harris, and J. M. Adams Transcriptional Regulation of vav, a Gene Expressed Throughout the Hematopoietic Compartment Blood, January 15, 1998; 91(2): 419 - 430. [Abstract] [Full Text] [PDF]

				H. Shigematsu, H. Iwasaki, T. Otsuka, Y. Ohno, F. Arima, and Y. Niho Role of the vav Proto-oncogene Product (Vav) in Erythropoietin-mediated Cell Proliferation and Phosphatidylinositol 3-Kinase Activity J. Biol. Chem., May 30, 1997; 272(22): 14334 - 14340. [Abstract] [Full Text] [PDF]

				B. Houssa, D. Schaap, J. van der Wal, K. Goto, H. Kondo, A. Yamakawa, M. Shibata, T. Takenawa, and W. J. van Blitterswijk Cloning of a Novel Human Diacylglycerol Kinase (DGKtheta ) Containing Three Cysteine-rich Domains, a Proline-rich Region, and a Pleckstrin Homology Domain with an Overlapping Ras-associating Domain J. Biol. Chem., April 18, 1997; 272(16): 10422 - 10428. [Abstract] [Full Text] [PDF]

				Y. Miyakawa, A. Oda, B. J. Druker, K. Ozaki, M. Handa, H. Ohashi, and Y. Ikeda Thrombopoietin and Thrombin Induce Tyrosine Phosphorylation of Vav in Human Blood Platelets Blood, April 15, 1997; 89(8): 2789 - 2798. [Abstract] [Full Text] [PDF]

				N Bonnefoy-Berard, A Munshi, I Yron, S Wu, T. Collins, M Deckert, T Shalom- Barak, L Giampa, E Herbert, J Hernandez, et al. Vav: function and regulation in hematopoietic cell signaling Stem Cells, May 1, 1996; 14(3): 250 - 268. [Abstract]

				I. Whitehead, H. Kirk, C. Tognon, G. Trigo-Gonzalez, and R. Kay Expression Cloning of lfc, a Novel Oncogene with Structural Similarities to Guanine Nucleotide Exchange Factors and to the Regulatory Region of Protein Kinase C J. Biol. Chem., August 4, 1995; 270(31): 18388 - 18395. [Abstract] [Full Text] [PDF]

				E Gulbins, K. Coggeshall, G Baier, S Katzav, P Burn, and A Altman Tyrosine kinase-stimulated guanine nucleotide exchange activity of Vav in T cell activation Science, May 7, 1993; 260(5109): 822 - 825. [Abstract] [PDF]

				X. R. Bustelo and M. Barbacid Tyrosine Phosphorylation of the vav Proto-Oncogene Product in Activated B Cells Science, May 22, 1992; 256(5060): 1196 - 1199. [Abstract] [PDF]

				C. Koch, D Anderson, M. Moran, C Ellis, and T Pawson SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins Science, May 3, 1991; 252(5006): 668 - 674. [Abstract] [PDF]

				L. Y. W. Bourguignon, H. Zhu, B. Zhou, F. Diedrich, P. A. Singleton, and M.-C. Hung Hyaluronan Promotes CD44v3-Vav2 Interaction with Grb2-p185HER2 and Induces Rac1 and Ras Signaling during Ovarian Tumor Cell Migration and Growth J. Biol. Chem., December 21, 2001; 276(52): 48679 - 48692. [Abstract] [Full Text] [PDF]

				M. Houlard, R. Arudchandran, F. Regnier-Ricard, A. Germani, S. Gisselbrecht, U. Blank, J. Rivera, and N. Varin-Blank Vav1 Is a Component of Transcriptionally Active Complexes J. Exp. Med., May 6, 2002; 195(9): 1115 - 1127. [Abstract] [Full Text] [PDF]